Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF

The angiotensin receptor/neprilysin inhibitor Sacubitril/Valsartan (Sac/Val) has been shown to be beneficial in patients suffering from heart failure with reduced ejection fraction (HFrEF). However, the impact of Sac/Val in patients presenting with heart failure with preserved ejection fraction (HFp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Schauer, Antje, Adams, Volker, Augstein, Antje, Jannasch, Anett, Draskowski, Runa, Kirchhoff, Virginia, Goto, Keita, Mittag, Jeniffer, Galli, Roberta, Männel, Anita, Barthel, Peggy, Linke, Axel, Winzer, Ephraim B.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036273/
https://ncbi.nlm.nih.gov/pubmed/33808232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22073570
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados